Aquestive Therapeutics Inc
AQST4.940USD
+0.110+2.28%
收盘 09/18, 16:00（美东）报价延迟15分钟
490.81M总市值
亏损市盈率 TTM
关于 Aquestive Therapeutics Inc 公司
Aquestive Therapeutics, Inc. 是一家制药公司。该公司正在开发药品，通过给药方式输送复杂分子，以替代侵入性和不方便的标准护理疗法。该公司正在推进治疗严重过敏反应（包括过敏反应）的产品线。该公司还开发了专注于治疗中枢神经系统 (CNS) 疾病的产品线。其 PharmFilm 技术由专有聚合物组合物组成，这些组合物可用作成膜剂来固定活性药物成分 (API) 和赋形剂。其产品组合和产品线包括 Anaphylm、AQST-108 和 Adrenaverse。其 CNS 候选产品包括 Libervant。该公司的许可商业产品和候选产品及其他产品包括 Suboxone、Exservan、KYNMOBI、Zuplenz、Azstarys、Libervant 和 Sympazan。Anaphylm 是一种非基于设备的口服肾上腺素候选产品。
公司简介
公司代码AQST
公司名称Aquestive Therapeutics Inc
上市日期Jul 25, 2018
CEOMr. Daniel Barber
员工数量142
证券类型Ordinary Share
年结日Jul 25
公司地址30 Technology Dr
城市WARREN
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编07059-5166
电话19089411900
网址https://aquestive.com/
公司代码AQST
上市日期Jul 25, 2018
CEOMr. Daniel Barber
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
302.75K
-3.45%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
288.11K
-4.95%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
281.66K
-4.15%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
181.86K
+15.94%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Dr. Marco Taglietti, M.D.
Dr. Marco Taglietti, M.D.
Independent Director
Independent Director
--
--
Mr. Timothy E. Morris, CPA
Mr. Timothy E. Morris, CPA
Independent Director
Independent Director
--
--
Ms. Stephanie Carrington
Ms. Stephanie Carrington
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
302.75K
-3.45%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
288.11K
-4.95%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
281.66K
-4.15%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
181.86K
+15.94%
收入明细
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暂无数据
地区USD
名称
营收
占比
United States
5.20M
0.00%
Ex-United States
3.52M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Crestline Investors, Inc.
8.13%
BlackRock Institutional Trust Company, N.A.
4.88%
The Vanguard Group, Inc.
3.59%
Millennium Management LLC
2.47%
Armistice Capital LLC
2.28%
其他
78.64%
持股股东
持股股东
占比
Crestline Investors, Inc.
8.13%
BlackRock Institutional Trust Company, N.A.
4.88%
The Vanguard Group, Inc.
3.59%
Millennium Management LLC
2.47%
Armistice Capital LLC
2.28%
其他
78.64%
股东类型
持股股东
占比
Hedge Fund
15.82%
Investment Advisor
14.76%
Investment Advisor/Hedge Fund
5.16%
Individual Investor
4.93%
Research Firm
3.74%
Private Equity
3.21%
Bank and Trust
0.11%
Insurance Company
0.03%
Pension Fund
0.02%
其他
52.24%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
267
54.90M
55.27%
-2.58M
2025Q1
270
54.42M
54.80%
-3.81M
2024Q4
246
52.68M
57.78%
-5.60M
2024Q3
235
56.04M
61.46%
+1.93M
2024Q2
197
48.34M
53.08%
-1.69M
2024Q1
166
46.95M
51.85%
+18.59M
2023Q4
129
27.01M
40.12%
+751.99K
2023Q3
131
26.75M
41.08%
+3.52M
2023Q2
143
22.79M
40.65%
+3.05M
2023Q1
161
18.71M
33.39%
-2.52M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Crestline Investors, Inc.
9.81M
9.88%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
5.48%
-78.94K
-1.43%
Mar 31, 2025
The Vanguard Group, Inc.
4.07M
4.1%
-273.20K
-6.29%
Mar 31, 2025
Armistice Capital LLC
2.75M
2.77%
+2.75M
--
Sep 30, 2024
Perceptive Advisors LLC
3.73M
3.75%
+3.73M
--
Mar 31, 2025
Geode Capital Management, L.L.C.
1.70M
1.71%
+46.11K
+2.79%
Mar 31, 2025
Barber (Daniel)
1.85M
1.86%
+462.91K
+33.44%
Mar 21, 2025
Pale Fire Capital SE
1.34M
1.34%
+809.93K
+154.05%
Mar 31, 2025
State Street Global Advisors (US)
1.52M
1.53%
+18.76K
+1.25%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
iShares Russell 3000 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
iShares Russell 2000 Value ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
iShares Micro-Cap ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Ultra Nasdaq Biotechnology
0%
Proshares Ultra Russell 2000
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 ETF
0%
查看更多
iShares Russell 3000 ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
Invesco Nasdaq Biotechnology ETF
占比0%
iShares Micro-Cap ETF
占比0%
ProShares UltraPro Russell2000
占比0%
ProShares Ultra Nasdaq Biotechnology
占比0%
Proshares Ultra Russell 2000
占比0%
Global X Russell 2000 ETF
占比0%
iShares Russell 2000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
